GlassScriptPhysician profile
Samuel B Latham
NPI 1740636729
$10,070.91
in general payments reported to CMS, 2019-2025
33 companies · $1,619 in 2025
The $1,619 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $397 · 2022: $393 · 2023: $831 · 2024: $6,830 · 2025: $1,619.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $5,750 · Food and Beverage: $3,531.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $5,750.00 |
| Food and Beverage | $3,531.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $5,782.55 | 2024-2025 | Auryon Laser System 100-120 Vac, Auryon Laser System 100-120 Vac |
| Medtronic, INC. | $572.45 | 2021-2025 | Corevalve Evolut R, Affera Mapping System |
| Abiomed | $548.70 | 2022-2025 | Impella |
| Pfizer INC. | $410.49 | 2023-2025 | |
| Boston Scientific Corporation | $384.93 | 2023-2025 | Watchman Flx, Ingevity+ |
| Shockwave Medical, INC | $288.56 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Novartis Pharmaceuticals Corporation | $272.54 | 2023-2025 | |
| Amgen INC. | $247.01 | 2023-2025 | Repatha, Repatha |
| E.R. Squibb & Sons, L.L.C. | $208.01 | 2024-2025 | Camzyos, Eliquis |
| Edwards Lifesciences Corporation | $156.27 | 2023-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Teleflex LLC | $150.47 | 2025 | Guideliner |
| Abbott Laboratories | $135.85 | 2021-2024 | Ensite |
| Inari Medical, INC. | $134.15 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Chiesi USA, INC. | $103.81 | 2021 | |
| Stryker Corporation | $97.54 | 2025 | Ct Thrombectomy System Kit, Artix Mt, Flowtriever Catheter, S |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $84.84 | 2024 | Penumbra System, Indigo System |
| Philips North America LLC | $80.30 | 2023-2025 | Ambulatory Monitoring & Diagnostics Undivided, (Cm9) Amb Mon & Diag Und, Mcot |
| Astrazeneca Pharmaceuticals LP | $51.13 | 2024-2025 | Farxiga |
| Janssen Pharmaceuticals, INC | $49.28 | 2023-2024 | Xarelto |
| Novo Nordisk INC | $38.46 | 2024-2025 | Wegovy |
| Esperion Therapeutics, INC. | $31.97 | 2024-2025 | Nexletol |
| Asahi Intecc USA, INC. | $31.37 | 2022 | |
| Terumo Medical Corporation | $29.26 | 2024 | Glidewire |
| W. L. Gore & Associates, INC. | $23.32 | 2025 | Gore Cardioform Asd Occluder |
| Regeneron Healthcare Solutions, INC. | $23.25 | 2025 | Evkeeza |
| Biotronik INC. | $22.04 | 2025 | Acticor 7 Vr-T Dx |
| Glaxosmithkline, LLC. | $18.24 | 2025 | Shingrix, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.85 | 2025 | Jardiance |
| Cvrx, INC. | $16.61 | 2025 | Barostim Neo System |
| Lexicon Pharmaceuticals, INC. | $15.55 | 2024 | |
| Merck Sharp & Dohme LLC | $15.44 | 2023 | Verquvo |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $15.15 | 2024 | Lifevest |
| Heartflow, INC. | $13.52 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Latham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.